Delivery Order SPE2DB25D3020-SPE2DB26FWGCN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $9,034.57 under a firm fixed price contract type. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $4,177.19 on July 21, 2025, with completion expected by July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes, with a ceiling value of $3,644.76 and a firm fixed price structure. This is a non-set-aside award representing a competitive procurement action. The order is due for completion by November 5, 2025, with performance to be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a contract ceiling value of $1,387.80. This firm fixed-price delivery order, issued on June 2, 2025, with a completion date of June 3, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes with a ceiling value of $1,744.15. This is a firm fixed-price delivery order representing a competitive award with no set-aside designation. The order is set for ultimate completion by August 26, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,939.00 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $14,315.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by August 15, 2025. The award represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a $1,721.52 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 11, 2025, with completion scheduled for September 12, 2025. This non-compete, firm fixed-price delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The award was issued without a set-aside designation, indicating competitive award status, and will be performed at...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB26FWGCNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $5,301.87 under firm fixed-price terms. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as the primary vehicle through which AmerisourceBergen supplies a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare systems and other federal customers globally. The company's significant federal pharmaceutical distribution portfolio with the DLA demonstrates its established role as a critical vendor for defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 11/10/25 |